nach oben

Journal of Community Health

Erschienen in:

01.06.2010 | Original paper

Mailed Fecal-Immunochemical Test for Colon Cancer Screening

verfasst von: Jeanette M. Daly, Barcey T. Levy, Mary L. Merchant, Jason Wilbur

Erschienen in: Journal of Community Health | Ausgabe 3/2010

Einloggen, um Zugang zu erhalten

Abstract

Various interventions have been implemented to increase the rate of colon cancer screening. The purpose of this study was to determine if persons who are regular patients of a clinic, ages 50–64 years, and not up-to-date with colon cancer screening will complete the at-home fecal-immunochemical test (FIT) if it is mailed to them. This intervention was designed to have the subject avoid the signing of an informed consent and having to ask for the screening test; and, only one stool specimen was needed. Three hundred and fifty potential subjects were randomly selected from an electronic medical record database after meeting inclusion criteria. Eighty-seven fecal immunochemical tests were returned. Seven of the FIT kit results were positive for occult blood. Each respondent was sent a letter giving them their results. A minimal cue CRC screening intervention, a FIT kit sent in the mail without prerequisite of a signed informed consent, was offered to the study subjects. Twenty-six percent of the eligible persons were screened for colon cancer by this method. A mailed FIT kit or one handed to the patient at an office visit has minimal cost which can be recovered through insurance coverage. Commitment by health care providers is necessary for prevention. This method is one of several that could reach the hard to screen population.

McFarland, E. G., Levin, B., Lieberman, D. A., Pickhardt, P. J., Johnson, C. D., Glick, S. N., Brooks, D., Smith, R. A., American Cancer Society, U.S. Multisociety Task Force on Colorectal Cancer, & American College of Radiology. (2008). Revised colorectal screening guidelines: joint effort of the American Cancer Society, U.S. Multisociety Task Force on Colorectal Cancer, and American College of Radiology. Radiology, 248(3), 717–720.

Surveillance, Epidemiology, and End Results (SEER) Program. (2000–2004). SEER Stat Database: Incidence—SEER 17 Regs Limited-Use, Nov 2006. www.seer.cancer.gov. Updated Released April 2007 based on the November 2006 submission.

Shapiro, J. A., Seeff, L. C., Thompson, T. D., Nadel, M. R., Klabunde, C. N., & Vernon, S. W. (2008). Colorectal cancer test use from the 2005 National Health Interview Survey. Cancer Epidemiology, Biomarkers and Prevention, 17(7), 1623–1630.CrossRefPubMed

Vogelaar, I., van Ballegooijen, M., Schrag, D., Boer, R., Winawer, S. J., Habbema, J. D., et al. (2006). How much can current interventions reduce colorectal cancer mortality in the U.S.? Mortality projections for scenarios of risk-factor modification, screening, and treatment. Cancer, 107(7), 1624–1633.CrossRefPubMed

Liang, S. Y., Phillips, K. A., Nagamine, M., Ladabaum, U., & Haas, J. S. (2006). Rates and predictors of colorectal cancer screening. Preventing Chronic Disease, 3(4), A117.PubMed

Hawley, S. T., Volk, R. J., Krishnamurthy, P., Jibaja-Weiss, M., Vernon, S. W., & Kneuper, S. (2008). Preferences for colorectal cancer screening among racially/ethnically diverse primary care patients. Medical Care, 46(9 Suppl 1), S10–S16.CrossRefPubMed

Klabunde, C. N., Lanier, D., Nadel, M. R., McLeod, C., Yuan, G., & Vernon, S. W. (2009). Colorectal cancer screening by primary care physicians: Recommendations and practices, 2006–2007. American Journal of Preventive Medicine, 37(1), 1–7.CrossRefPubMed

Pignone, M., Harris, R., & Kinsinger, L. (2000). Videotape-based decision aid for colon cancer screening. A randomized, controlled trial. Annals of Internal Medicine, 133(10), 761–769.PubMed

Sequist, T. D., Zaslavsky, A. M., Marshall, R., Fletcher, R. H., & Ayanian, J. Z. (2009). Patient and physician reminders to promote colorectal cancer screening: A randomized controlled trial. Archives of Internal Medicine, 169(4), 364–371.CrossRefPubMed

10.

Chan, E. C., & Vernon, S. W. (2008). Implementing an intervention to promote colon cancer screening through e-mail over the Internet: Lessons learned from a pilot study. Medical Care, 46(9 Suppl 1), S117–S122.CrossRefPubMed

11.

Khankari, K., Eder, M., Osborn, C. Y., Makoul, G., Clayman, M., Skripkauskas, S., et al. (2007). Improving colorectal cancer screening among the medically underserved: A pilot study within a federally qualified health center. Journal of General Internal Medicine, 22(10), 1410–1414.CrossRefPubMed

12.

Vernon, S. W. (1997). Participation in colorectal cancer screening: A review. Journal of the National Cancer Institute, 89(19), 1406–1422.CrossRefPubMed

13.

Yarnall, K. S., Pollak, K. I., Ostbye, T., Krause, K. M., & Michener, J. L. (2003). Primary care: Is there enough time for prevention? American Journal of Public Health, 93(4), 635–641.CrossRefPubMed

14.

Levy, B. T., Joshi, M., Xu, Y., Daly, J., & James, P. A. (2008). Perceptions of Iowa family physicians regarding colorectal cancer screening. Medical Care, 46(9 Suppl 1), S103–S108.CrossRefPubMed

15.

Schroy, P. C., I. I. I., Lal, S., Glick, J. T., Robinson, P. A., Zamor, P., & Heeren, T. C. (2007). Patient preferences for colorectal cancer screening: How does stool DNA testing fare? American Journal of Managed Care, 13(7), 393–400.PubMed

16.

Pignone, M. (2007). Patient preferences for colon cancer screening: The role of out-of-pocket costs. American Journal of Managed Care, 13(7), 390–391.PubMed

17.

Ling, B. S., Moskowitz, M. A., Wachs, D., Pearson, B., & Schroy, P. C. (2001). Attitudes toward colorectal cancer screening tests. Journal of General Internal Medicine, 16(12), 822–830.CrossRefPubMed

18.

Parekh, M., Fendrick, A. M., & Ladabaum, U. (2008). As tests evolve and costs of cancer care rise: Reappraising stool-based screening for colorectal neoplasia. Alimentary Pharmacology & Therapeutics, 27(8), 697–712.CrossRef

19.

Levin, B., Lieberman, D. A., McFarland, B., Andrews, K. S., Brooks, D., Bond, J., Dash, C., Giardiello, F. M., Glick, S., Johnson, D., Johnson, C. D., Levin, T. R., Pickhardt, P. J., Rex, D. K., Smith, R. A., Thorson, A., Winawer, S. J., American Cancer Society Colorectal Cancer Advisory Group, US Multi-Society Task Force, & American College of Radiology Colon Cancer Committee. (2008). Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: A joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology, 134(5), 1570–1595.

20.

Allison, J. E., Sakoda, L. C., Levin, T. R., Tucker, J. P., Tekawa, I. S., Cuff, T., et al. (2007). Screening for colorectal neoplasms with new fecal occult blood tests: Update on performance characteristics. Journal of the National Cancer Institute, 99(19), 1462–1470.CrossRefPubMed

21.

Lee, F. I. (1983). Screening for colorectal cancer in a factory-based population with Fecatest. British Journal of Cancer, 48(6), 843–847.PubMed

22.

Sontag, S. J., Durczak, C., Aranha, G. V., Chejfec, G., Frederick, W., & Greenlee, H. B. (1983). Fecal occult blood screening for colorectal cancer in a Veterans Administration Hospital. American Journal of Surgery, 145(1), 89–94.CrossRefPubMed

23.

Slater, P. E., Fich, A., Zimmerman, J., Ever-Hadani, P., & Rachmilewitz, D. (1985). Recruitment of subjects for fecal occult blood screening: A comparison of two methods in Jerusalem. Journal of Clinical Gastroenterology, 7(1), 51–54.CrossRefPubMed

24.

St John, D. J., Young, G. P., Alexeyeff, M. A., Deacon, M. C., Cuthbertson, A. M., Macrae, F. A., et al. (1993). Evaluation of new occult blood tests for detection of colorectal neoplasia. Gastroenterology, 104(6), 1661–1668.PubMed

25.

Castiglione, G., Zappa, M., Grazzini, G., Mazzotta, A., Biagini, M., Salvadori, P., et al. (1996). Immunochemical vs guaiac faecal occult blood tests in a population-based screening programme for colorectal cancer. British Journal of Cancer, 74(1), 141–144.PubMed

26.

Lohsiriwat, V., Thavichaigarn, P., & Awapittaya, B. (2007). A multicenter prospective study of immunochemical fecal occult blood testing for colorectal cancer detection. Journal of the Medical Association of Thailand, 90(11), 2291–2295.PubMed

27.

Inverness Medical. (2009). Fecal occult blood tests: Clearview ULTRA FOB test. Clearview ULTRA FOB Test Web site. http://www.clearview-fobt.com. Updated 2009. Accessed May 11, 2009.

28.

Church, T. R., Yeazel, M. W., Jones, R. M., Kochevar, L. K., Watt, G. D., Mongin, S. J., et al. (2004). A randomized trial of direct mailing of fecal occult blood tests to increase colorectal cancer screening. Journal of the National Cancer Institute, 96(10), 770–780.PubMed

29.

Hardcastle, J. D., Armitage, N. C., Chamberlain, J., Amar, S. S., James, P. D., & Balfour, T. W. (1986). Fecal occult blood screening for colorectal cancer in the general population. Results of a controlled trial. Cancer, 58(2), 397–403.CrossRefPubMed

30.

Pye, G., Christie, M., Chamberlain, J. O., Moss, S. M., & Hardcastle, J. D. (1988). A comparison of methods for increasing compliance within a general practitioner based screening project for colorectal cancer and the effect on practitioner workload. Journal of Epidemiology and Community Health, 42(1), 66–71.CrossRefPubMed

31.

Mant, D., Fuller, A., Northover, J., Astrop, P., Chivers, A., Crockett, A., et al. (1992). Patient compliance with colorectal cancer screening in general practice. British Journal of General Practice, 42(354), 18–20.PubMed

32.

Greegor, D. H. (1971). Occult blood testing for detection of asymptomatic colon cancer. Cancer, 28(1), 131–134.CrossRefPubMed

33.

Anderson, L. M., & May, D. S. (1995). Has the use of cervical, breast, and colorectal cancer screening increased in the United States? American Journal of Public Health, 85(6), 840–842.CrossRefPubMed

34.

Brown, M. L., Potosky, A. L., Thompson, G. B., & Kessler, L. G. (1990). The knowledge and use of screening tests for colorectal and prostate cancer: Data from the 1987 National Health Interview Survey. Preventive Medicine, 19(5), 562–574.CrossRefPubMed

35.

Schenck, A. P., Peacock, S. C., Klabunde, C. N., Lapin, P., Coan, J. F., & Brown, M. L. (2009). Trends in colorectal cancer test use in the medicare population, 1998–2005. American Journal of Preventive Medicine, 37(1), 1–7.CrossRefPubMed

Titel: Mailed Fecal-Immunochemical Test for Colon Cancer Screening
verfasst von: Jeanette M. Daly
Barcey T. Levy
Mary L. Merchant
Jason Wilbur
Publikationsdatum: 01.06.2010
Verlag: Springer US
Erschienen in: Journal of Community Health / Ausgabe 3/2010
Print ISSN: 0094-5145
Elektronische ISSN: 1573-3610
DOI: https://doi.org/10.1007/s10900-010-9227-8

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2010

Emergency Preparedness Training and Response Among Community Health Centers and Local Health Departments: Results from a Multi-State Survey

Beyond Affordability: The Impact of Nonfinancial Barriers on Access for Uninsured Adults in Three Diverse Communities

A Small Grants Program to Involve Communities in Research

MPH Program Adaptability in a Competitive Marketplace: The Case for Continued Assessment

Need to Improve Routine HIV Testing of U.S. Veterans in Care: Results of an Internet Survey

Circumstances, Pedagogy and Rationales for Injection Initiation Among New Drug Injectors